Subscribe
Interview with the Innovators

Deciding Which Patients Are Best Suited for Various First-Line Pancreatic Cancer Treatment Options

Interview with the Innovators
Pancreatic Cancer Patient Education
Videos
Tanios S. Bekaii-Saab, MD
David F. and Margaret T. Grohne Professor of Novel Therapeutics for Cancer Research
Chair and Consultant, Division of Hematology and Medical Oncology
Professor, Mayo Clinic College of Medicine and Science, Scottsdale, AZ
Shubham Pant, MD
Professor, GI Medical Oncology
MD Anderson Cancer Center, Houston, TX
Michael Pishvaian, MD, PhD
Associate Professor of Oncology
Johns Hopkins University, Washington, DC

In this eighth installment, Shubham Pant, MD, and Michael Pishvaian, MD, PhD, discuss their approach on deciding which treatment options, FOLFIRINOX or NALIRIFOX, are best suited for the patients that they treat.

Related Items

The Role of Biomarker Testing: Educating Patients and Advancing Endometrial Cancer Care
By Paula Anastasia, MN, RN, AOCN; Susanne Menon, DNP, WHNP-BC, OCN, ACHPN
Videos
Interview with the Innovators
Evaluating Treatment Options: Key Clinical Considerations in Endometrial Cancer Care
By Paula Anastasia, MN, RN, AOCN; Susanne Menon, DNP, WHNP-BC, OCN, ACHPN
Videos
Interview with the Innovators
Providing Holistic Support: Emotional and Practical Resources for Patients With Endometrial Cancer
By Paula Anastasia, MN, RN, AOCN; Susanne Menon, DNP, WHNP-BC, OCN, ACHPN
Videos
Interview with the Innovators
Initiating Treatment Conversations: Educating Patients on Endometrial Cancer Options
By Paula Anastasia, MN, RN, AOCN; Susanne Menon, DNP, WHNP-BC, OCN, ACHPN
Videos
Interview with the Innovators
Advancements in Endometrial Cancer Treatment: The Role of Personalized Medicine
By Paula Anastasia, MN, RN, AOCN; Susanne Menon, DNP, WHNP-BC, OCN, ACHPN
Videos
Interview with the Innovators
Best Practices for Managing Side Effects in Endometrial Cancer
By Paula Anastasia, MN, RN, AOCN; Susanne Menon, DNP, WHNP-BC, OCN, ACHPN
Videos
Interview with the Innovators
Deciding Between Triplet Therapy for the Treatment of Pancreatic Cancer: NALIRIFOX and FOLFIRINOX
By Tanios S. Bekaii-Saab, MD; Shubham Pant, MD; Michael Pishvaian, MD, PhD
Videos
Interview with the Innovators
Considerations for Selecting a First-Line Pancreatic Cancer Treatment
By Tanios S. Bekaii-Saab, MD; Shubham Pant, MD; Michael Pishvaian, MD, PhD
Videos
Interview with the Innovators
How the Cost of Cancer Treatments May Affect Treatment Decisions for Patients
By Tanios S. Bekaii-Saab, MD; Shubham Pant, MD; Michael Pishvaian, MD, PhD
Videos
Interview with the Innovators
Best Practices for Treating Adverse Events Associated With Pancreatic Cancer Therapies
By Tanios S. Bekaii-Saab, MD; Shubham Pant, MD; Michael Pishvaian, MD, PhD
Videos
Interview with the Innovators

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Sign Up for The Oncology Nurse®‑APN/PA

Subscribe to receive the free, TON print publication, and TON Bi-Weekly e‑newsletter.

Subscribe

Amplity

© Amplity, Inc. All Rights Reserved. Privacy Policy.

We Value Your Feedback! Tell Us How You Consume Content

Your feedback will help us tailor our content to better meet your needs and preferences.

*First Name
*Last Name
*Email
*What's your favorite format for experiencing our content?